Showing results (31-40 of 323) with videos related to
Sort By:
Pageof 33
Gynecologic Oncology|May 1, 1993
The use of recombinant human erythropoietin to prevent carboplatin-induced anemiaM Markman, B Reichman, T Hakes, et al.Journal of the National Cancer Institute. Monographs|January 1, 1993
Intraperitoneal administration of Taxol in the management of ovarian cancerM Markman, E Rowinsky, T Hakes, et al.Gynecologic Oncology|May 24, 2001
Identification of risk factors for requiring transfusion during front-line chemotherapy for ovarian cancerM L Hensley, D Lebeau, L F Leon, et al.Gynecologic Oncology|May 1, 1993
Salvage intraperitoneal mitoxantrone therapy of ovarian cancer: influence of increasing the volume of treatmentM Markman, T Hakes, B Reichman, et al.Gynecologic Oncology|December 11, 1992
Phase 2 trial of intraperitoneal carboplatin and etoposide as salvage treatment of advanced epithelial ovarian cancerM Markman, B Reichman, T Hakes, et al.The European Journal of Surgery = Acta Chirurgica|December 5, 2002
High rate of recurrence after lobectomy for solitary thyroid noduleMaunzio Marchesi, Marco Biffoni, Cristiana Faloci, et al.International Surgery|December 31, 1998
Total versus subtotal thyroidectomy in the management of multinodular goiterM Marchesi, M Biffoni, F Tartaglia, et al.Bioresource Technology|October 31, 2006
Beta-chitin from the pens of Loligo sp.: extraction and characterizationRodrigo L Lavall, Odilio B G Assis, Sérgio P Campana-FilhoJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 1991
Intraperitoneal cisplatin and cytarabine in the treatment of refractory or recurrent ovarian carcinomaM Markman, T Hakes, B Reichman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 11, 1992
Impact on survival of surgically defined favorable responses to salvage intraperitoneal chemotherapy in small-volume residual ovarian cancerM Markman, B Reichman, T Hakes, et al.Pageof 33